Maria L. Blanco
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD.
Journal: Frontiers in immunology
Published: November 10, 2025
Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations.
Journal: HemaSphere
Published: February 24, 2025
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype.
Journal: Cancers
Published: June 14, 2022
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.
Journal: Molecular oncology
Published: January 24, 2022
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients.
Journal: Haematologica
Published: November 27, 2020
Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report.
Journal: Clinical case reports
Published: April 20, 2020
Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5-azacytidine: Identification of responding patients.
Journal: European journal of haematology
Published: March 26, 2019
Ultrastructural, cytogenetic, and molecular findings in mast cell leukemia: Case report.
Journal: Clinical case reports
Published: November 15, 2018
Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report.
Journal: Medicina clinica
Published: July 06, 2018
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group.
Journal: Leukemia research
Published: July 02, 2017
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
Journal: American journal of hematology
Published: March 13, 2017
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions.
Journal: Oncotarget
Published: March 03, 2017
Last Updated: 09/26/2026